Hospital Infection Prevention And Control Market Insights, Global Outlook and Forecast 2022-2028
Hospital Infection Prevention And Control Market Insights, Global Outlook and Forecast 2022-2028
Hospital Infection Prevention And Control Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Hospital acquired infections are a growing issue of preventable disease burden in respect of morbidity and mortality in all countries.
The latest research study released by Market IntelliX evaluates market size and forecasts of Hospital Infection Prevention And Control in Global, including the following market information:
Global Hospital Infection Prevention And Control Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hospital Infection Prevention And Control market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Infection Prevention Supplies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hospital Infection Prevention And Control include 3M Company, Ansell Ltd., Belimed AG, Bemis Company, Inc., B. Braun Melsungen AG, Cantel Medical Corp., Cardinal Health, Inc., Covidien plc. and Crosstex International, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Hospital Infection Prevention And Control companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Hospital Infection Prevention And Control Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hospital Infection Prevention And Control Market Segment Percentages, by Type, 2021 (%)
Infection Prevention Supplies
Infection Prevention Equipment
Infection Prevention Services
Global Hospital Infection Prevention And Control Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hospital Infection Prevention And Control Market Segment Percentages, by Application, 2021 (%)
Pneumonia
Urinary Tract Infection
Blood Stream Infection
Surgical Site Infection
MRSA
Global Hospital Infection Prevention And Control Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hospital Infection Prevention And Control Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hospital Infection Prevention And Control revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hospital Infection Prevention And Control revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
3M Company
Ansell Ltd.
Belimed AG
Bemis Company, Inc.
B. Braun Melsungen AG
Cantel Medical Corp.
Cardinal Health, Inc.
Covidien plc.
Crosstex International, Inc.
Danaher Corp.
Diversey, Inc.
Getinge Group
Johnson & Johnson
Halyard Health, Inc.
Matachana Group
Medivators, Inc.
Purdue Pharma LP
Sealed Air Corp.
Semperit AG Holding
Synergy Health plc.
Terumo Corp.
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Hospital Infection Prevention And Control Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital Infection Prevention And Control Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hospital Infection Prevention And Control Overall Market Size
2.1 Global Hospital Infection Prevention And Control Market Size: 2021 VS 2028
2.2 Global Hospital Infection Prevention And Control Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hospital Infection Prevention And Control Players in Global Market
3.2 Top Global Hospital Infection Prevention And Control Companies Ranked by Revenue
3.3 Global Hospital Infection Prevention And Control Revenue by Companies
3.4 Top 3 and Top 5 Hospital Infection Prevention And Control Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hospital Infection Prevention And Control Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital Infection Prevention And Control Players in Global Market
3.6.1 List of Global Tier 1 Hospital Infection Prevention And Control Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital Infection Prevention And Control Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Hospital Infection Prevention And Control Market Size Markets, 2021 & 2028
4.1.2 Infection Prevention Supplies
4.1.3 Infection Prevention Equipment
4.1.4 Infection Prevention Services
4.2 By Type - Global Hospital Infection Prevention And Control Revenue & Forecasts
4.2.1 By Type - Global Hospital Infection Prevention And Control Revenue, 2017-2022
4.2.2 By Type - Global Hospital Infection Prevention And Control Revenue, 2023-2028
4.2.3 By Type - Global Hospital Infection Prevention And Control Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hospital Infection Prevention And Control Market Size, 2021 & 2028
5.1.2 Pneumonia
5.1.3 Urinary Tract Infection
5.1.4 Blood Stream Infection
5.1.5 Surgical Site Infection
5.1.6 MRSA
5.2 By Application - Global Hospital Infection Prevention And Control Revenue & Forecasts
5.2.1 By Application - Global Hospital Infection Prevention And Control Revenue, 2017-2022
5.2.2 By Application - Global Hospital Infection Prevention And Control Revenue, 2023-2028
5.2.3 By Application - Global Hospital Infection Prevention And Control Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Hospital Infection Prevention And Control Market Size, 2021 & 2028
6.2 By Region - Global Hospital Infection Prevention And Control Revenue & Forecasts
6.2.1 By Region - Global Hospital Infection Prevention And Control Revenue, 2017-2022
6.2.2 By Region - Global Hospital Infection Prevention And Control Revenue, 2023-2028
6.2.3 By Region - Global Hospital Infection Prevention And Control Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Hospital Infection Prevention And Control Revenue, 2017-2028
6.3.2 US Hospital Infection Prevention And Control Market Size, 2017-2028
6.3.3 Canada Hospital Infection Prevention And Control Market Size, 2017-2028
6.3.4 Mexico Hospital Infection Prevention And Control Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Hospital Infection Prevention And Control Revenue, 2017-2028
6.4.2 Germany Hospital Infection Prevention And Control Market Size, 2017-2028
6.4.3 France Hospital Infection Prevention And Control Market Size, 2017-2028
6.4.4 U.K. Hospital Infection Prevention And Control Market Size, 2017-2028
6.4.5 Italy Hospital Infection Prevention And Control Market Size, 2017-2028
6.4.6 Russia Hospital Infection Prevention And Control Market Size, 2017-2028
6.4.7 Nordic Countries Hospital Infection Prevention And Control Market Size, 2017-2028
6.4.8 Benelux Hospital Infection Prevention And Control Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Hospital Infection Prevention And Control Revenue, 2017-2028
6.5.2 China Hospital Infection Prevention And Control Market Size, 2017-2028
6.5.3 Japan Hospital Infection Prevention And Control Market Size, 2017-2028
6.5.4 South Korea Hospital Infection Prevention And Control Market Size, 2017-2028
6.5.5 Southeast Asia Hospital Infection Prevention And Control Market Size, 2017-2028
6.5.6 India Hospital Infection Prevention And Control Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Hospital Infection Prevention And Control Revenue, 2017-2028
6.6.2 Brazil Hospital Infection Prevention And Control Market Size, 2017-2028
6.6.3 Argentina Hospital Infection Prevention And Control Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital Infection Prevention And Control Revenue, 2017-2028
6.7.2 Turkey Hospital Infection Prevention And Control Market Size, 2017-2028
6.7.3 Israel Hospital Infection Prevention And Control Market Size, 2017-2028
6.7.4 Saudi Arabia Hospital Infection Prevention And Control Market Size, 2017-2028
6.7.5 UAE Hospital Infection Prevention And Control Market Size, 2017-2028
7 Players Profiles
7.1 3M Company
7.1.1 3M Company Corporate Summary
7.1.2 3M Company Business Overview
7.1.3 3M Company Hospital Infection Prevention And Control Major Product Offerings
7.1.4 3M Company Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.1.5 3M Company Key News
7.2 Ansell Ltd.
7.2.1 Ansell Ltd. Corporate Summary
7.2.2 Ansell Ltd. Business Overview
7.2.3 Ansell Ltd. Hospital Infection Prevention And Control Major Product Offerings
7.2.4 Ansell Ltd. Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.2.5 Ansell Ltd. Key News
7.3 Belimed AG
7.3.1 Belimed AG Corporate Summary
7.3.2 Belimed AG Business Overview
7.3.3 Belimed AG Hospital Infection Prevention And Control Major Product Offerings
7.3.4 Belimed AG Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.3.5 Belimed AG Key News
7.4 Bemis Company, Inc.
7.4.1 Bemis Company, Inc. Corporate Summary
7.4.2 Bemis Company, Inc. Business Overview
7.4.3 Bemis Company, Inc. Hospital Infection Prevention And Control Major Product Offerings
7.4.4 Bemis Company, Inc. Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.4.5 Bemis Company, Inc. Key News
7.5 B. Braun Melsungen AG
7.5.1 B. Braun Melsungen AG Corporate Summary
7.5.2 B. Braun Melsungen AG Business Overview
7.5.3 B. Braun Melsungen AG Hospital Infection Prevention And Control Major Product Offerings
7.5.4 B. Braun Melsungen AG Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.5.5 B. Braun Melsungen AG Key News
7.6 Cantel Medical Corp.
7.6.1 Cantel Medical Corp. Corporate Summary
7.6.2 Cantel Medical Corp. Business Overview
7.6.3 Cantel Medical Corp. Hospital Infection Prevention And Control Major Product Offerings
7.6.4 Cantel Medical Corp. Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.6.5 Cantel Medical Corp. Key News
7.7 Cardinal Health, Inc.
7.7.1 Cardinal Health, Inc. Corporate Summary
7.7.2 Cardinal Health, Inc. Business Overview
7.7.3 Cardinal Health, Inc. Hospital Infection Prevention And Control Major Product Offerings
7.7.4 Cardinal Health, Inc. Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.7.5 Cardinal Health, Inc. Key News
7.8 Covidien plc.
7.8.1 Covidien plc. Corporate Summary
7.8.2 Covidien plc. Business Overview
7.8.3 Covidien plc. Hospital Infection Prevention And Control Major Product Offerings
7.8.4 Covidien plc. Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.8.5 Covidien plc. Key News
7.9 Crosstex International, Inc.
7.9.1 Crosstex International, Inc. Corporate Summary
7.9.2 Crosstex International, Inc. Business Overview
7.9.3 Crosstex International, Inc. Hospital Infection Prevention And Control Major Product Offerings
7.9.4 Crosstex International, Inc. Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.9.5 Crosstex International, Inc. Key News
7.10 Danaher Corp.
7.10.1 Danaher Corp. Corporate Summary
7.10.2 Danaher Corp. Business Overview
7.10.3 Danaher Corp. Hospital Infection Prevention And Control Major Product Offerings
7.10.4 Danaher Corp. Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.10.5 Danaher Corp. Key News
7.11 Diversey, Inc.
7.11.1 Diversey, Inc. Corporate Summary
7.11.2 Diversey, Inc. Business Overview
7.11.3 Diversey, Inc. Hospital Infection Prevention And Control Major Product Offerings
7.11.4 Diversey, Inc. Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.11.5 Diversey, Inc. Key News
7.12 Getinge Group
7.12.1 Getinge Group Corporate Summary
7.12.2 Getinge Group Business Overview
7.12.3 Getinge Group Hospital Infection Prevention And Control Major Product Offerings
7.12.4 Getinge Group Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.12.5 Getinge Group Key News
7.13 Johnson & Johnson
7.13.1 Johnson & Johnson Corporate Summary
7.13.2 Johnson & Johnson Business Overview
7.13.3 Johnson & Johnson Hospital Infection Prevention And Control Major Product Offerings
7.13.4 Johnson & Johnson Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.13.5 Johnson & Johnson Key News
7.14 Halyard Health, Inc.
7.14.1 Halyard Health, Inc. Corporate Summary
7.14.2 Halyard Health, Inc. Business Overview
7.14.3 Halyard Health, Inc. Hospital Infection Prevention And Control Major Product Offerings
7.14.4 Halyard Health, Inc. Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.14.5 Halyard Health, Inc. Key News
7.15 Matachana Group
7.15.1 Matachana Group Corporate Summary
7.15.2 Matachana Group Business Overview
7.15.3 Matachana Group Hospital Infection Prevention And Control Major Product Offerings
7.15.4 Matachana Group Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.15.5 Matachana Group Key News
7.16 Medivators, Inc.
7.16.1 Medivators, Inc. Corporate Summary
7.16.2 Medivators, Inc. Business Overview
7.16.3 Medivators, Inc. Hospital Infection Prevention And Control Major Product Offerings
7.16.4 Medivators, Inc. Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.16.5 Medivators, Inc. Key News
7.17 Purdue Pharma LP
7.17.1 Purdue Pharma LP Corporate Summary
7.17.2 Purdue Pharma LP Business Overview
7.17.3 Purdue Pharma LP Hospital Infection Prevention And Control Major Product Offerings
7.17.4 Purdue Pharma LP Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.17.5 Purdue Pharma LP Key News
7.18 Sealed Air Corp.
7.18.1 Sealed Air Corp. Corporate Summary
7.18.2 Sealed Air Corp. Business Overview
7.18.3 Sealed Air Corp. Hospital Infection Prevention And Control Major Product Offerings
7.18.4 Sealed Air Corp. Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.18.5 Sealed Air Corp. Key News
7.19 Semperit AG Holding
7.19.1 Semperit AG Holding Corporate Summary
7.19.2 Semperit AG Holding Business Overview
7.19.3 Semperit AG Holding Hospital Infection Prevention And Control Major Product Offerings
7.19.4 Semperit AG Holding Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.19.5 Semperit AG Holding Key News
7.20 Synergy Health plc.
7.20.1 Synergy Health plc. Corporate Summary
7.20.2 Synergy Health plc. Business Overview
7.20.3 Synergy Health plc. Hospital Infection Prevention And Control Major Product Offerings
7.20.4 Synergy Health plc. Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.20.5 Synergy Health plc. Key News
7.21 Terumo Corp.
7.21.1 Terumo Corp. Corporate Summary
7.21.2 Terumo Corp. Business Overview
7.21.3 Terumo Corp. Hospital Infection Prevention And Control Major Product Offerings
7.21.4 Terumo Corp. Hospital Infection Prevention And Control Revenue in Global Market (2017-2022)
7.21.5 Terumo Corp. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Hospital Infection Prevention And Control Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|